APO Research
Talk to an analyst

APO RESEARCH · REPORT

Posterior Pituitary for Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Posterior Pituitary for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025182 pages

Choose your research edition.

Industry ResearchPosterior Pituitary for Injection Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Posterior Pituitary for Injection Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Posterior Pituitary for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Posterior Pituitary for Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Posterior Pituitary for Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Posterior Pituitary for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Posterior Pituitary for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Posterior Pituitary for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Posterior Pituitary for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Posterior Pituitary for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Posterior Pituitary for Injection include Anhui Hongye Pharmaceutical, Beijing Science Sun, Chengdu Hepatunn Pharmaceutical, Kamp Pharmaceutical, Nanjing Xinbai Pharmaceutical, Shanghai Harvest Pharmaceutical, Shanghai No. 1 Biochemical & Pharmaceutical and Eisai (Liaoning) Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Posterior Pituitary for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Posterior Pituitary for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Posterior Pituitary for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Posterior Pituitary for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Posterior Pituitary for Injection Segment by Company

Anhui Hongye Pharmaceutical

Beijing Science Sun

Chengdu Hepatunn Pharmaceutical

Kamp Pharmaceutical

Nanjing Xinbai Pharmaceutical

Shanghai Harvest Pharmaceutical

Shanghai No. 1 Biochemical & Pharmaceutical

Eisai (Liaoning) Pharmaceutical

Posterior Pituitary for Injection Segment by Type

Intramuscular Injection

Intravenous Drip

Posterior Pituitary for Injection Segment by Application

Obstetric Oxytocia

Lung or Bronchi Bleeding

Gastrointestinal Bleeding

Others

Posterior Pituitary for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Posterior Pituitary for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Posterior Pituitary for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Posterior Pituitary for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Posterior Pituitary for Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Posterior Pituitary for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Posterior Pituitary for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Posterior Pituitary for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Posterior Pituitary for Injection Industry Trends Table 2. Posterior Pituitary for Injection Industry Drivers Table 3. Posterior Pituitary for Injection Industry Opportunities and Challenges Table 4. Posterior Pituitary for Injection Industry Restraints Table 5. Global Posterior Pituitary for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Posterior Pituitary for Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Posterior Pituitary for Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Posterior Pituitary for Injection Sales Market Share by Manufacturers Table 9. Global Posterior Pituitary for Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Posterior Pituitary for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Posterior Pituitary for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Posterior Pituitary for Injection Manufacturers, Product Type & Application Table 13. Global Posterior Pituitary for Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Posterior Pituitary for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Intramuscular Injection Table 17. Major Manufacturers of Intravenous Drip Table 18. Global Posterior Pituitary for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Posterior Pituitary for Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Posterior Pituitary for Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Posterior Pituitary for Injection Sales Market Share by Type (2021-2026) Table 22. Global Posterior Pituitary for Injection Sales Market Share by Type (2027-2032) Table 23. Global Posterior Pituitary for Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Posterior Pituitary for Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Posterior Pituitary for Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Posterior Pituitary for Injection Revenue Market Share by Type (2021-2026) Table 27. Global Posterior Pituitary for Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Obstetric Oxytocia Table 29. Major Manufacturers of Lung or Bronchi Bleeding Table 30. Major Manufacturers of Gastrointestinal Bleeding Table 31. Major Manufacturers of Others Table 32. Global Posterior Pituitary for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Posterior Pituitary for Injection Sales by Application (2021-2026) & (K Units) Table 34. Global Posterior Pituitary for Injection Sales by Application (2027-2032) & (K Units) Table 35. Global Posterior Pituitary for Injection Sales Market Share by Application (2021-2026) Table 36. Global Posterior Pituitary for Injection Sales Market Share by Application (2027-2032) Table 37. Global Posterior Pituitary for Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Posterior Pituitary for Injection Revenue by Application (2021-2026) & (K Units) Table 39. Global Posterior Pituitary for Injection Revenue by Application (2027-2032) & (K Units) Table 40. Global Posterior Pituitary for Injection Revenue Market Share by Application (2021-2026) Table 41. Global Posterior Pituitary for Injection Revenue Market Share by Application (2027-2032) Table 42. Global Posterior Pituitary for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Posterior Pituitary for Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Posterior Pituitary for Injection Sales Market Share by Region (2021-2026) Table 45. Global Posterior Pituitary for Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Posterior Pituitary for Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Posterior Pituitary for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Posterior Pituitary for Injection Sales by Country (2021-2026) & (K Units) Table 49. North America Posterior Pituitary for Injection Sales by Country (2027-2032) & (K Units) Table 50. Europe Posterior Pituitary for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Posterior Pituitary for Injection Sales by Country (2021-2026) & (K Units) Table 52. Europe Posterior Pituitary for Injection Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Posterior Pituitary for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Posterior Pituitary for Injection Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Posterior Pituitary for Injection Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Posterior Pituitary for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Posterior Pituitary for Injection Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Posterior Pituitary for Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Posterior Pituitary for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Posterior Pituitary for Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Posterior Pituitary for Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Posterior Pituitary for Injection Revenue Market Share by Region (2021-2026) Table 63. Global Posterior Pituitary for Injection Revenue Market Share by Region (2027-2032) Table 64. Anhui Hongye Pharmaceutical Company Information Table 65. Anhui Hongye Pharmaceutical Business Overview Table 66. Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Product Portfolio Table 68. Anhui Hongye Pharmaceutical Recent Development Table 69. Beijing Science Sun Company Information Table 70. Beijing Science Sun Business Overview Table 71. Beijing Science Sun Posterior Pituitary for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Beijing Science Sun Posterior Pituitary for Injection Product Portfolio Table 73. Beijing Science Sun Recent Development Table 74. Chengdu Hepatunn Pharmaceutical Company Information Table 75. Chengdu Hepatunn Pharmaceutical Business Overview Table 76. Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Product Portfolio Table 78. Chengdu Hepatunn Pharmaceutical Recent Development Table 79. Kamp Pharmaceutical Company Information Table 80. Kamp Pharmaceutical Business Overview Table 81. Kamp Pharmaceutical Posterior Pituitary for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Kamp Pharmaceutical Posterior Pituitary for Injection Product Portfolio Table 83. Kamp Pharmaceutical Recent Development Table 84. Nanjing Xinbai Pharmaceutical Company Information Table 85. Nanjing Xinbai Pharmaceutical Business Overview Table 86. Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Product Portfolio Table 88. Nanjing Xinbai Pharmaceutical Recent Development Table 89. Shanghai Harvest Pharmaceutical Company Information Table 90. Shanghai Harvest Pharmaceutical Business Overview Table 91. Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Product Portfolio Table 93. Shanghai Harvest Pharmaceutical Recent Development Table 94. Shanghai No. 1 Biochemical & Pharmaceutical Company Information Table 95. Shanghai No. 1 Biochemical & Pharmaceutical Business Overview Table 96. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Product Portfolio Table 98. Shanghai No. 1 Biochemical & Pharmaceutical Recent Development Table 99. Eisai (Liaoning) Pharmaceutical Company Information Table 100. Eisai (Liaoning) Pharmaceutical Business Overview Table 101. Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Product Portfolio Table 103. Eisai (Liaoning) Pharmaceutical Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Posterior Pituitary for Injection Distributors List Table 107. Posterior Pituitary for Injection Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Posterior Pituitary for Injection Product Image Figure 2. Global Posterior Pituitary for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Posterior Pituitary for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Posterior Pituitary for Injection Sales (2021-2032) & (K Units) Figure 5. Global Posterior Pituitary for Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Posterior Pituitary for Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Intramuscular Injection Image Figure 9. Intravenous Drip Image Figure 10. Global Posterior Pituitary for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Posterior Pituitary for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Posterior Pituitary for Injection Sales Market Share by Type (2021-2032) Figure 13. Global Posterior Pituitary for Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Posterior Pituitary for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Posterior Pituitary for Injection Revenue Market Share by Type (2021-2032) Figure 16. Obstetric Oxytocia Image Figure 17. Lung or Bronchi Bleeding Image Figure 18. Gastrointestinal Bleeding Image Figure 19. Others Image Figure 20. Global Posterior Pituitary for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Posterior Pituitary for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Posterior Pituitary for Injection Sales Market Share by Application (2021-2032) Figure 23. Global Posterior Pituitary for Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Posterior Pituitary for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Posterior Pituitary for Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Posterior Pituitary for Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Posterior Pituitary for Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Posterior Pituitary for Injection Sales Market Share by Country (2021-2032) Figure 40. China Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Posterior Pituitary for Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Posterior Pituitary for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Posterior Pituitary for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Posterior Pituitary for Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Posterior Pituitary for Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Posterior Pituitary for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Posterior Pituitary for Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Posterior Pituitary for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Posterior Pituitary for Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Posterior Pituitary for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Posterior Pituitary for Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Posterior Pituitary for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Posterior Pituitary for Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Posterior Pituitary for Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Injection
  • Intravenous Drip
Applications
  • Obstetric Oxytocia
  • Lung or Bronchi Bleeding
  • Gastrointestinal Bleeding
  • Others
Companies covered
  • Anhui Hongye Pharmaceutical
  • Beijing Science Sun
  • Chengdu Hepatunn Pharmaceutical
  • Kamp Pharmaceutical
  • Nanjing Xinbai Pharmaceutical
  • Shanghai Harvest Pharmaceutical
  • Shanghai No. 1 Biochemical & Pharmaceutical
  • Eisai (Liaoning) Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Posterior Pituitary for Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Posterior Pituitary for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Posterior Pituitary for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Posterior Pituitary for Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Posterior Pituitary for Injection Market Dynamics
  1. 2.1 Posterior Pituitary for Injection Industry Trends
  2. 2.2 Posterior Pituitary for Injection Industry Drivers
  3. 2.3 Posterior Pituitary for Injection Industry Opportunities and Challenges
  4. 2.4 Posterior Pituitary for Injection Industry Restraints
3 Posterior Pituitary for Injection Market by Manufacturers
  1. 3.1 Global Posterior Pituitary for Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Posterior Pituitary for Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Posterior Pituitary for Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Posterior Pituitary for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Posterior Pituitary for Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Posterior Pituitary for Injection Manufacturers, Product Type & Application
  7. 3.7 Global Posterior Pituitary for Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Posterior Pituitary for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Posterior Pituitary for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Posterior Pituitary for Injection Tier 1, Tier 2, and Tier 3
4 Posterior Pituitary for Injection Market by Type
  1. 4.1 Posterior Pituitary for Injection Type Introduction
  2. 4.1.1 Intramuscular Injection
  3. 4.1.2 Intravenous Drip
  4. 4.2 Global Posterior Pituitary for Injection Sales by Type
  5. 4.2.1 Global Posterior Pituitary for Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Posterior Pituitary for Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Posterior Pituitary for Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Posterior Pituitary for Injection Revenue by Type
  9. 4.3.1 Global Posterior Pituitary for Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Posterior Pituitary for Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Posterior Pituitary for Injection Revenue Market Share by Type (2021-2032)
5 Posterior Pituitary for Injection Market by Application
  1. 5.1 Posterior Pituitary for Injection Application Introduction
  2. 5.1.1 Obstetric Oxytocia
  3. 5.1.2 Lung or Bronchi Bleeding
  4. 5.1.3 Gastrointestinal Bleeding
  5. 5.1.4 Others
  6. 5.2 Global Posterior Pituitary for Injection Sales by Application
  7. 5.2.1 Global Posterior Pituitary for Injection Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Posterior Pituitary for Injection Sales by Application (2021-2032)
  9. 5.2.3 Global Posterior Pituitary for Injection Sales Market Share by Application (2021-2032)
  10. 5.3 Global Posterior Pituitary for Injection Revenue by Application
  11. 5.3.1 Global Posterior Pituitary for Injection Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Posterior Pituitary for Injection Revenue by Application (2021-2032)
  13. 5.3.3 Global Posterior Pituitary for Injection Revenue Market Share by Application (2021-2032)
6 Global Posterior Pituitary for Injection Sales by Region
  1. 6.1 Global Posterior Pituitary for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Posterior Pituitary for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Posterior Pituitary for Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Posterior Pituitary for Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Posterior Pituitary for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Posterior Pituitary for Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Posterior Pituitary for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Posterior Pituitary for Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Posterior Pituitary for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Posterior Pituitary for Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Posterior Pituitary for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Posterior Pituitary for Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Posterior Pituitary for Injection Revenue by Region
  1. 7.1 Global Posterior Pituitary for Injection Revenue by Region
  2. 7.1.1 Global Posterior Pituitary for Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Posterior Pituitary for Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Posterior Pituitary for Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Posterior Pituitary for Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Posterior Pituitary for Injection Revenue (2021-2032)
  8. 7.2.2 North America Posterior Pituitary for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Posterior Pituitary for Injection Revenue (2021-2032)
  11. 7.3.2 Europe Posterior Pituitary for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Posterior Pituitary for Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Posterior Pituitary for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Posterior Pituitary for Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Posterior Pituitary for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Anhui Hongye Pharmaceutical
  2. 8.1.1 Anhui Hongye Pharmaceutical Company Information
  3. 8.1.2 Anhui Hongye Pharmaceutical Business Overview
  4. 8.1.3 Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Anhui Hongye Pharmaceutical Posterior Pituitary for Injection Product Portfolio
  6. 8.1.5 Anhui Hongye Pharmaceutical Recent Developments
  7. 8.2 Beijing Science Sun
  8. 8.2.1 Beijing Science Sun Company Information
  9. 8.2.2 Beijing Science Sun Business Overview
  10. 8.2.3 Beijing Science Sun Posterior Pituitary for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Science Sun Posterior Pituitary for Injection Product Portfolio
  12. 8.2.5 Beijing Science Sun Recent Developments
  13. 8.3 Chengdu Hepatunn Pharmaceutical
  14. 8.3.1 Chengdu Hepatunn Pharmaceutical Company Information
  15. 8.3.2 Chengdu Hepatunn Pharmaceutical Business Overview
  16. 8.3.3 Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chengdu Hepatunn Pharmaceutical Posterior Pituitary for Injection Product Portfolio
  18. 8.3.5 Chengdu Hepatunn Pharmaceutical Recent Developments
  19. 8.4 Kamp Pharmaceutical
  20. 8.4.1 Kamp Pharmaceutical Company Information
  21. 8.4.2 Kamp Pharmaceutical Business Overview
  22. 8.4.3 Kamp Pharmaceutical Posterior Pituitary for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kamp Pharmaceutical Posterior Pituitary for Injection Product Portfolio
  24. 8.4.5 Kamp Pharmaceutical Recent Developments
  25. 8.5 Nanjing Xinbai Pharmaceutical
  26. 8.5.1 Nanjing Xinbai Pharmaceutical Company Information
  27. 8.5.2 Nanjing Xinbai Pharmaceutical Business Overview
  28. 8.5.3 Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nanjing Xinbai Pharmaceutical Posterior Pituitary for Injection Product Portfolio
  30. 8.5.5 Nanjing Xinbai Pharmaceutical Recent Developments
  31. 8.6 Shanghai Harvest Pharmaceutical
  32. 8.6.1 Shanghai Harvest Pharmaceutical Company Information
  33. 8.6.2 Shanghai Harvest Pharmaceutical Business Overview
  34. 8.6.3 Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Harvest Pharmaceutical Posterior Pituitary for Injection Product Portfolio
  36. 8.6.5 Shanghai Harvest Pharmaceutical Recent Developments
  37. 8.7 Shanghai No. 1 Biochemical & Pharmaceutical
  38. 8.7.1 Shanghai No. 1 Biochemical & Pharmaceutical Company Information
  39. 8.7.2 Shanghai No. 1 Biochemical & Pharmaceutical Business Overview
  40. 8.7.3 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai No. 1 Biochemical & Pharmaceutical Posterior Pituitary for Injection Product Portfolio
  42. 8.7.5 Shanghai No. 1 Biochemical & Pharmaceutical Recent Developments
  43. 8.8 Eisai (Liaoning) Pharmaceutical
  44. 8.8.1 Eisai (Liaoning) Pharmaceutical Company Information
  45. 8.8.2 Eisai (Liaoning) Pharmaceutical Business Overview
  46. 8.8.3 Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eisai (Liaoning) Pharmaceutical Posterior Pituitary for Injection Product Portfolio
  48. 8.8.5 Eisai (Liaoning) Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Posterior Pituitary for Injection Value Chain Analysis
  2. 9.1.1 Posterior Pituitary for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Posterior Pituitary for Injection Production Mode & Process
  6. 9.2 Posterior Pituitary for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Posterior Pituitary for Injection Distributors
  9. 9.2.3 Posterior Pituitary for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst